S6 Ep28: Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
Feb 17, 2022
14:06
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Milhem discusses the unique mechanism of action and delivery method of RP1, which is being evaluated in the IGNYTE trial for patients with solid tumors, as well as the parallel studies ARTACUS and CERPASS, which are further exploring the agent.
OncLive® On Air